Skip to content

Clinical trials

Essential Hypertension trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Status: Unknown status Country / region: China Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20135
20141
20151
20163
20171
20182
20191
20203
20211
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Chao Yang Hospital2
Chinese Academy of Medical Sciences, Fuwai Hospital2
Shenzhen Ausa Pharmed Co.,Ltd2
Shenzhen People's Hospital2
The Second Affiliated Hospital of Chongqing Medical University2
Beijing Institute of Heart, Lung and Blood Vessel Diseases1
First Affiliated Hospital, Sun Yat-Sen University1
Guangdong Provincial People's Hospital1
Hasten Biopharmaceutical Co., Ltd.1
Ji Xunming,MD,PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension25
Hypertension5
Cardiovascular Diseases3
Acute Coronary Syndrome1
Coronary Disease1
Cytomegalovirus Infections1
Diabetes Mellitus, Type 21
Endocrine System Diseases1
Epilepsy1
Hyperaldosteronism1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.